Patient-reported outcomes (PROs) in patients (pts) with pancreatic neuroendocrine tumors (NET) receiving sunitinib (SU) in a phase III trial Meeting Abstract

Industry Collaboration International Collaboration

author list

  • Vinik, A., Bang, Y., Raoul, J., Valle, J. W., Metrakos, P., Hoersch, D., Korytowsky, B., Mundayat, R., Chao, R. C., Raymond, E.

authors

publication date

  • May 20, 2010

webpage

published in

category

volume

  • 28

issue

  • 15